Medicare Enrolled

Dr. Marjan Farid, MD

Ophthalmology · Irvine, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
850 HEALTH SCIENCES RD, Irvine, CA 92617
9498242020
In practice since 2006 (19 years)
NPI: 1275589756 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Farid from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farid? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Farid

Dr. Marjan Farid is an ophthalmology specialist in Irvine, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Farid performed 2,733 Medicare services across 2,190 unique beneficiaries.

Between the years covered by Open Payments, Dr. Farid received a total of $642,275 from 35 pharmaceutical and/or device companies across 566 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Farid is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 36% volume in CA $642,275 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,733
Medicare services
Top 36% in CA for ophthalmology
2,190
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~144 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
460 $73 $430
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
427 $50 $291
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
426 $24 $140
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
348 $15 $90
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
326 $20 $125
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
295 $479 $3,040
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
186 $103 $654
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
80 $347 $2,223
Slit lamp examination of the eye
This procedure uses a specialized microscope to examine the front portion of the eye.
77 $16 $139
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
43 $664 $4,371
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
31 $16 $125
Corneal transplant, outer layer
Surgical procedure to replace the outer layer of the cornea with donor tissue.
23 $1,035 $5,325
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $51 $392
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.6% high complexity
25.8% medium
62.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$642,275
Total received (2018-2024)
Avg $91,754/year across 7 years
Top 1% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
566
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$441,463 (68.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198,890 (31.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,922 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$96,330
2023
$87,490
2022
$104,176
2021
$65,418
2020
$94,228
2019
$131,016
2018
$63,617

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Johnson & Johnson Surgical Vision, Inc.
$30,580
Bausch & Lomb Americas Inc.
$18,342
Oyster Point Pharma, Inc.
$17,282
Alcon Research LLC
$15,643
Alcon Vision LLC
$5,500
ABBVIE INC.
$2,113
Harrow Eye, LLC
$1,400
Glaukos Corporation
$1,398
Carl Zeiss Meditec, Inc.
$1,117
Tarsus Pharmaceuticals, Inc.
$1,058
BIOTISSUE HOLDINGS INC.
$1,000
Sight Sciences, Inc.
$750
RxSight Inc
$98
Amgen Inc.
$50
Top 3 companies account for 68.7% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Surgical Vision, Inc.
$293,355
Oyster Point Pharma, Inc.
$59,327
Bausch & Lomb Americas Inc.
$46,500
Dompe US, Inc.
$34,159
Allergan, Inc.
$28,735
Shire North American Group Inc
$27,695
Novartis Pharmaceuticals Corporation
$19,888
Alcon Research LLC
$17,043
Kala Pharmaceuticals, Inc.
$16,588
Alcon Vision LLC
$13,550
Bausch & Lomb, a division of Bausch Health US, LLC
$11,818
Carl Zeiss Meditec, Inc.
$11,709
TissueTech, Inc.
$10,595
Allergan Inc.
$10,565
ABBVIE INC.
$7,488
TISSUETECH, INC.
$6,550
Sight Sciences, Inc.
$4,859
Sun Pharmaceutical Industries Inc.
$3,745
NOVARTIS PHARMACEUTICALS CORPORATION
$3,325
GLAUKOS CORPORATION
$2,927
Eyevance Pharmaceuticals LLC
$2,311
Glaukos Corporation
$2,242
EyePoint Pharmaceuticals US, Inc.
$1,819
Harrow Eye, LLC
$1,400
Tarsus Pharmaceuticals, Inc.
$1,058
BIOTISSUE HOLDINGS INC.
$1,000
RxSight Inc
$627
Beaver-Visitec International, Inc.
$600
Katena Products, Inc.
$250
Carl Zeiss Meditec USA, Inc.
$163
Apellis Pharmaceuticals, Inc.
$113
Mallinckrodt Hospital Products Inc.
$100
Ocular Therapeutix, Inc.
$81
Amgen Inc.
$50
Quidel Corporation
$40
Top 3 companies account for 62.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMO PHACO NEEDLE · AMVISC · ARTEVO 800 · AcrySof · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BLINK NUTRITEARS · BromSite (bromfenac ophthalmic solution) 0.075% · CALLISTO eye · CATALYS Laser System · CATALYS SYSTEM · CE-marked KXLA system · CEQUA · CIRRUS HD-OCT · Catalys Laser System · Catalys System · Cataract Suite · Compact Intuitiv · DEXYCU · DURYSTA · ENVISTA · ENVISTA TORIC · EYSUVIS · Flarex · Healon Duet Pro · Healon Viscoelastics · ILINK · INTRALASE FS FEMTOSEC LASER · INVELTYS · IOLMaster 500 · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · InflammaDry · KXL system (not refurbished) · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) · LOTEMAX SM · LUMIGAN · MIEBO · OPMI Lumera 700 · OXERVATE · OZURDEX · Ophthalmic Surgical Adjuncts · Oxervate · PROKERA · PROLENSA · Photrexa · Premium Cataract IOLs · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSure Sealant · STELLARIS ELITE · STELLARIS PC · Syfovre · TEARCARE SYSTEM · TECNIS IOL · TYRVAYA · TearCare · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · Tecnis Symfony IOL · VERACITY SURGICAL · VERITAS Vision System · VEVYE · VUITY · VisuMax · Wavelight · XDEMVY · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · iStent Trabecular Micro-Bypass System Model iS3
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (69%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for ophthalmology in CA.

Looking for an ophthalmology specialist in Irvine?
Compare ophthalmologists in the Irvine area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
359
Per 100K population
11.3
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Farid is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Farid experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Farid performed 460 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farid receive payments from pharmaceutical companies?
Yes. Dr. Farid received a total of $642,275 from 35 companies across 566 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farid's costs compare to other ophthalmologists in Irvine?
Dr. Farid's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farid) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →